Exchange: NASDAQ·Updated 04:20 PM EDT
IMVT logo

IMVT Immunovant Inc

$39.12
$0.37
(0.94%)
Today
Closed $39.12
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$8.16B
Vol1.19M

About IMVT

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded on July 6, 2018 and is headquartered in Durham, NC.
60

Bullish Sentiment

How do you feel about IMVT?

Advertisement|Remove ads.